Fwd: [jjworld] Digest Number 376

[Guest guest]

In a message dated 02/18/2004 9:29:53 AM Eastern Standard Time, jjworld writes:

WORLD OF MS UPDATE SERVICE, 17 February 2004>>Research News>====================>>Comparison of the effects of acetyl l-carnitine and amantadine for the>treatment of fatigue in multiple sclerosis: results of a pilot, randomised,>double-blind, crossover trial.>-------------------->The present study reports the results of a randomised, double-blind,>crossover study comparing the efficacy of Amantadine and acetyl l-carnitine>in the treatment of multiple sclerosis related fatigue.>http://www.msif.org/go.rm?id=11027>>Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism>in a multiple sclerosis population.>-------------------->The results of the present study rule out the possibility of a relationship>between genetic variations in the neuronal form of the enzyme nitric oxide>synthase and susceptibility to multiple sclerosis.>http://www.msif.org/go.rm?id=11028>>Correlations between multiple sclerosis functional composite, expanded>disability status scale and health-related quality of life during and after>treatment of relapses in patients with multiple sclerosis.>-------------------->The authors examine the clinical changes as measured by different scales>(multiple sclerosis functional composite -MSFC- and EDSS) during and after>corticosteroid treatment for relapses of multiple sclerosis.>http://www.msif.org/go.rm?id=11029>>Functional imaging during covert auditory attention in multiple sclerosis.>-------------------->In this positron emission topography (PET) study the authors demonstrate>cerebral reorganization during auditory attention in patients with multiple>sclerosis.>http://www.msif.org/go.rm?id=11030>>Efficacy of Sildenafil in the Treatment of Female Sexual Dysfunction Due to>Multiple Sclerosis.>-------------------->Sildenafil is found to be of limited benefit in treating female sexual>dysfunction in this double-blind, randomized, placebo controlled crossover>study. Lubrication was the only domain in which sildenafil treatment had a>significant effect.>http://www.msif.org/go.rm?id=11031>>Trends in survival and cause of death in Danish patients with multiple>sclerosis.>-------------------->This paper examines the trends in survival and cause of death in all Danish>patients with disease onset between 1949 and 1996. The probability for>survival is found to be significantly improved during the period of study.>http://www.msif.org/go.rm?id=11032>>Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a>cohort study of 490 patients.>-------------------->The authors present their experience with cyclophosphamide treatment in>patients with primary and secondary progressive multiple sclerosis.>http://www.msif.org/go.rm?id=11033>>Multiple sclerosis: expression of CD1a and production of IL-12p70 and>IFN-gamma by blood mononuclear cells in patients on combination therapy>with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.>-------------------->The present study investigates the immunological changes occurring in>patients with multiple sclerosis treated with immunomodulatory drugs.>http://www.msif.org/go.rm?id=11034>>Diffusion tensor imaging of early relapsing-remitting multiple sclerosis>with histogram analysis using automated segmentation and brain volume>correction.>-------------------->The present study employs diffusion tensor imaging to demonstrate>abnormalities in the normal-appearing brain tissue of patients with early>relapsing-remitting multiple sclerosis.>http://www.msif.org/go.rm?id=11035>>Concordance for disease course and age of onset in Scandinavian multiple>sclerosis coaffected sib pairs.>-------------------->The results of the present study suggest that genetic features may partly>determine the disease course and age at onset in patients with multiple>sclerosis.>http://www.msif.org/go.rm?id=11036>>Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis:>differences in repeated cerebrospinal fluid examinations.>-------------------->This study reports differences in the presence and temporal pattern of>oligoclonal bands between patients with multiple sclerosis and patients>with Devic’s neuromyelitis optica.>http://www.msif.org/go.rm?id=11037>>>>---Drop into Jooly's Joint: our award-winning online communityfor people living with Multiple Sclerosishttp://www.mswebpals.org Email: jooly@...---New Statesman New Media Award winner 2000Yell UK Web Award winner 2000---MS Society (UK) http://www.mssociety.org.ukMS Society (USA) http://www.nmss.orgMS Trust (UK) http://www.mstrust.org.ukMS Resource Centre (UK) http://www.msrc.co.ukWorld of MS http://www.msif.org

There is 1 message in this issue.

Topics in this digest:

1. Fwd: World of MS Update Service

From: Jooly's Joint <jooly@...>

________________________________________________________________________

________________________________________________________________________

Message: 1

Date: Tue, 17 Feb 2004 19:52:57 +0000

From: Jooly's Joint <jooly@...>

Subject: Fwd: World of MS Update Service

>

>

>WORLD OF MS UPDATE SERVICE, 17 February 2004

>

>Research News

>====================

>

>Comparison of the effects of acetyl l-carnitine and amantadine for the

>treatment of fatigue in multiple sclerosis: results of a pilot, randomised,

>double-blind, crossover trial.

>--------------------

>The present study reports the results of a randomised, double-blind,

>crossover study comparing the efficacy of Amantadine and acetyl l-carnitine

>in the treatment of multiple sclerosis related fatigue.

>http://www.msif.org/go.rm?id=11027

>

>Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism

>in a multiple sclerosis population.

>--------------------

>The results of the present study rule out the possibility of a relationship

>between genetic variations in the neuronal form of the enzyme nitric oxide

>synthase and susceptibility to multiple sclerosis.

>http://www.msif.org/go.rm?id=11028

>

>Correlations between multiple sclerosis functional composite, expanded

>disability status scale and health-related quality of life during and after

>treatment of relapses in patients with multiple sclerosis.

>--------------------

>The authors examine the clinical changes as measured by different scales

>(multiple sclerosis functional composite -MSFC- and EDSS) during and after

>corticosteroid treatment for relapses of multiple sclerosis.

>http://www.msif.org/go.rm?id=11029

>

>Functional imaging during covert auditory attention in multiple sclerosis.

>--------------------

>In this positron emission topography (PET) study the authors demonstrate

>cerebral reorganization during auditory attention in patients with multiple

>sclerosis.

>http://www.msif.org/go.rm?id=11030

>

>Efficacy of Sildenafil in the Treatment of Female Sexual Dysfunction Due to

>Multiple Sclerosis.

>--------------------

>Sildenafil is found to be of limited benefit in treating female sexual

>dysfunction in this double-blind, randomized, placebo controlled crossover

>study. Lubrication was the only domain in which sildenafil treatment had a

>significant effect.

>http://www.msif.org/go.rm?id=11031

>

>Trends in survival and cause of death in Danish patients with multiple

>sclerosis.

>--------------------

>This paper examines the trends in survival and cause of death in all Danish

>patients with disease onset between 1949 and 1996. The probability for

>survival is found to be significantly improved during the period of study.

>http://www.msif.org/go.rm?id=11032

>

>Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a

>cohort study of 490 patients.

>--------------------

>The authors present their experience with cyclophosphamide treatment in

>patients with primary and secondary progressive multiple sclerosis.

>http://www.msif.org/go.rm?id=11033

>

>Multiple sclerosis: expression of CD1a and production of IL-12p70 and

>IFN-gamma by blood mononuclear cells in patients on combination therapy

>with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.

>--------------------

>The present study investigates the immunological changes occurring in

>patients with multiple sclerosis treated with immunomodulatory drugs.

>http://www.msif.org/go.rm?id=11034

>

>Diffusion tensor imaging of early relapsing-remitting multiple sclerosis

>with histogram analysis using automated segmentation and brain volume

>correction.

>--------------------

>The present study employs diffusion tensor imaging to demonstrate

>abnormalities in the normal-appearing brain tissue of patients with early

>relapsing-remitting multiple sclerosis.

>http://www.msif.org/go.rm?id=11035

>

>Concordance for disease course and age of onset in Scandinavian multiple

>sclerosis coaffected sib pairs.

>--------------------

>The results of the present study suggest that genetic features may partly

>determine the disease course and age at onset in patients with multiple

>sclerosis.

>http://www.msif.org/go.rm?id=11036

>

>Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis:

>differences in repeated cerebrospinal fluid examinations.

>--------------------

>This study reports differences in the presence and temporal pattern of

>oligoclonal bands between patients with multiple sclerosis and patients

>with Devic’s neuromyelitis optica.

>http://www.msif.org/go.rm?id=11037

>

>

>

>

---

Drop into Jooly's Joint: our award-winning online community

for people living with Multiple Sclerosis

http://www.mswebpals.org Email: jooly@...

---

New Statesman New Media Award winner 2000

Yell UK Web Award winner 2000

---

MS Society (UK) http://www.mssociety.org.uk

MS Society (USA) http://www.nmss.org

MS Trust (UK) http://www.mstrust.org.uk

MS Resource Centre (UK) http://www.msrc.co.uk

World of MS http://www.msif.org

---

The perfect present!

'The Wish List' CD sold to raise funds for MS research.

http://www.mswebpals.org/wishlist.htm

________________________________________________________________________

________________________________________________________________________

------------------------------------------------------------------------